BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22192531)

  • 21. EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
    Vashakidze E; Mikadze I
    Georgian Med News; 2015 Oct; (247):54-8. PubMed ID: 26483375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crimean-Congo haemorrhagic fever among children in north-eastern Turkey.
    Dilber E; Cakir M; Acar EA; Orhan F; Yaris N; Bahat E; Okten A; Erduran E
    Ann Trop Paediatr; 2009 Mar; 29(1):23-8. PubMed ID: 19222930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.
    Yilmaz GR; Buzgan T; Irmak H; Safran A; Uzun R; Cevik MA; Torunoglu MA
    Int J Infect Dis; 2009 May; 13(3):380-6. PubMed ID: 18986819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
    Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
    Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of brucellosis and Crimean-Congo hemorrhagic fever coinfection in an endemic area].
    Karakeçili F; Çıkman A; Akın H; Gülhan B; Özçiçek A
    Mikrobiyol Bul; 2016 Apr; 50(2):322-7. PubMed ID: 27175506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resting heart rate in children with Crimean-Congo hemorrhagic fever: a tool to identify patients at risk?
    Oflaz MB; Bolat F; Kaya A; Guven AS; Kucukdurmaz Z; Karapinar H; Gulsever O; Dogan M; Cevit O; Icagasioglu FD
    Vector Borne Zoonotic Dis; 2014 Jan; 14(1):59-65. PubMed ID: 24359422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.
    Gozdas HT
    Afr Health Sci; 2019 Mar; 19(1):1433-1440. PubMed ID: 31148970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children].
    Karaaslan E; Çetin Ş
    Mikrobiyol Bul; 2021 Apr; 55(2):180-193. PubMed ID: 33882650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
    Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
    Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological characteristics, clinical and laboratory findings supporting preliminary diagnosis of Crimean-Congo hemorrhagic fever in an endemic region in Turkey.
    Yeşilbağ Z; Karadeniz A; Koçulu S; Kayhan CB
    Wien Klin Wochenschr; 2020 Oct; 132(19-20):581-588. PubMed ID: 32749537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aetiology of PCR negative suspected Crimean-Congo hemorrhagic fever cases in an endemic area.
    Tanyel E; Sunbul M; Fletcher TE; Leblebicioglu H
    Pathog Glob Health; 2016; 110(4-5):173-7. PubMed ID: 27677379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical examiners and Crimean-Congo hemorrhagic fever contamination risk.
    Ozsoy S; Gokmen A; Ozdemir M; Akduman B; Korkusuz I; Javan GT
    J Forensic Leg Med; 2015 Nov; 36():32-6. PubMed ID: 26367781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever].
    Karaşahin Ö; Karaşahin EF
    Mikrobiyol Bul; 2021 Jul; 55(3):327-341. PubMed ID: 34416800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First Crimean-Congo hemorrhagic fever outbreak in India.
    Patel AK; Patel KK; Mehta M; Parikh TM; Toshniwal H; Patel K
    J Assoc Physicians India; 2011 Sep; 59():585-9. PubMed ID: 22334974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
    Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
    J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever.
    Kaygusuz TÖ; Tartar AS; Balin ŞÖ; Akbulut A; Demirdağ K
    Biomark Med; 2023 Jun; 17(11):533-540. PubMed ID: 37791843
    [No Abstract]   [Full Text] [Related]  

  • 37. Crimean Congo hemorrhagic fever in Hazara division.
    Malik S; Diju IU; Naz F
    J Ayub Med Coll Abbottabad; 2011; 23(2):90-2. PubMed ID: 24800352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
    Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
    Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
    Uyar Y; Carhan A; Albayrak N; Altaş AB
    Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Crimean-Congo Hemorrhagic Fever].
    Güneş T
    Mikrobiyol Bul; 2006 Jul; 40(3):279-87. PubMed ID: 17001860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.